Sex differences in immunity
Men and women have measurably different immune responses:
- Women mount stronger antibody responses to vaccines
- Women have ~3-4x higher autoimmune disease rates
- Men have more severe outcomes from many infections (sepsis, severe COVID)
- Men have lower baseline CRP and certain inflammatory markers
- Women have higher T-cell counts and broader T-cell repertoires
Sex hormones, testosterone in men, estrogen in women, are major contributors to these differences.
Testosterone immune effects
Testosterone is generally immunosuppressive:
- Reduces antibody production by B-cells
- Reduces T-cell activation
- Modulates cytokine production (typically reducing pro-inflammatory)
- Reduces NK cell activity
- Modulates innate immunity
This is functional, not pathological, appropriate immune suppression prevents excessive autoimmune activation. The trade-off may be slightly weaker pathogen response.
Low T immune dysregulation
Low testosterone is often associated with chronic inflammation rather than reduced inflammation:
- Elevated hs-CRP
- Elevated IL-6 and TNF-α
- Elevated fibrinogen
- Higher cardiovascular and metabolic disease rates
The mechanism appears to be loss of testosterone's modulatory function, without T's anti-inflammatory tempering, low-grade chronic inflammation develops, often interacting with metabolic dysfunction.
TRT effect on inflammation
TRT in men with low T:
- Reduces hs-CRP
- Reduces inflammatory cytokines
- Reduces fibrinogen
- Modestly reduces other inflammation markers
Effects are typically modest but consistent. Combined with the metabolic, body composition, and cardiovascular improvements, the inflammation reduction contributes to overall benefit.
Supratherapeutic concerns
Very high testosterone (above physiologic ranges, as in performance-enhancing doses) may suppress immune function more substantially. Anecdotal reports of increased infection rates in supratherapeutic users exist but data is limited. For TRT, staying in physiologic range optimizes immune function rather than impairing it.
COVID era data
The COVID-19 pandemic produced data on sex hormones and infection severity:
- Men had ~2× mortality from COVID
- Low testosterone in men admitted with COVID predicted worse outcomes
- Both very high and very low T associated with worse outcomes
- Estradiol may have protective effects in women
The relationship between sex hormones and infection severity is complex but suggests adequate physiologic levels are protective.
The clinical insight: Testosterone modulates immunity bidirectionally. Optimal levels appear protective; both deficiency and excess can produce immune dysregulation. TRT to physiologic range tends to normalize chronic inflammation in low-T patients.
Bottom line
Testosterone modulates immune function. Low T produces chronic low-grade inflammation; restoration normalizes inflammatory state. Very high T may impair pathogen response. The optimal range supports balanced immunity. For OPTML patients on TRT, inflammation marker improvements are part of the overall benefit.